Turning physiology

into intelligence.

Vision

Empowering people to understand their health in real time and to apply those insights to live better, longer lives.

Mission

We turn the body’s hidden signals into clear, actionable intelligence that helps people stay healthier, safer and performing at their best. With novel sensing and physiology‑guided AI, we deliver key insights that are easy to understand, simple to act on and powerful at scale, giving people real‑time visibility and control over their wellbeing and performance.

Your body is speaking.

We're learning its language.

Continuous physiological insights. Built for better decisions.

WearOptimo is developing AI-native physiology guided technology to help people live healthier, longer lives – by enabling continuous, personalised insight into their physiological state. Our platform is designed to support human performance, readiness, safety and wellness while expanding what wearables can monitor. 

THE BACKING OF A CHAMPION

Mark Webber AO

Hydration explained

F1 Grand Prix winner Mark Webber AO on why it’s so critical to measure hydration in elite sport and beyond.

Timeline

Future

AI-native physiological intelligence platform

Expand and integrate new human physiological states, biomarkers and health applications beyond hydration monitoring.

Future

Commercial deployment.

Launch hydration and heat-risk wearable solutions across first priority markets.

Future

Expanded field testing, human trials and scaling manufacturing

Expand field trials, user feedback testing, human studies and manufacturing capacity build-out

2026

Platform validation

Validate beta sensors through proprietary data generation, physiology-informed AI, human studies and field pilots.

2026

With issuance of additional patents.

2025

Successful completion of clinical pilot study

Established proof of concept for hydration Microwearable device

2025

With distinguished global leaders in key relevant areas of WearOptimo; including Dr. Robert Langer (MIT Professor), creator of many category-defining deep-tech life sciences technologies and businesses. Co-founder of Moderna.

2024

The first phase of the multi-million-dollar facility is completed, uniquely deploying Nano Imprint Lithography – capable of making 30 million Microwearable sensor chips (per year), at a cost of less than 10 cents each.

2023

Backing of a champion

F1 Grand Prix winner Mark Webber AO signs on as both a strategic partner and investor

2023

Human trials commence

First human trials begin for prototype hydration Microwearable sensor

2022

Aspen Medical invests in WearOptimo and signs a commercial distribution agreement for specific markets of interest.

2021

Significant Australian Federal Government support

Department of Industry, Science, Energy and Resources grants almost $1 million under the Manufacturing Modernisation Fund

2021

Strong state government backing

Queensland Government announces multimillion-dollar support to produce pilot manufacturing facility

2020

Key patent

First Hydration Microwearable patent granted in Australia

2018 & 2019

Innovation recognition

First grant funding from Life Sciences Innovator MTPConnect

2018

Foundational Partnership with ANU

Australian National University comes on board as foundational investor

2018

Start of the journey

Professor Mark Kendall establishes WearOptimo in Brisbane, Australia.